Fifth Cohort of Brain Health Equity Nurse Fellowship to Advance Early Detection in Black and Latino Communities

UsAgainstAlzheimer’s today announced the launch of the fifth cohort of its Brain Health Equity Nurse Fellowship, a national initiative designed to close persistent gaps in early detection of Alzheimer’s disease and related dementias and expand culturally tailored brain health education in communities disproportionately affected by the disease.

Leading the Way: Black Women Closing the Gap in Brain Health

As we celebrate Black History Month and head into Women’s History Month, one thing is clear: progress in Alzheimer’s research has never happened without bold, intentional leadership. And today, some of the most powerful forces reshaping the future of brain health are Black women scientists.

UsAgainstAlzheimer’s President Russ Paulsen on Why Funding Alzheimer’s Research Is Urgent

UsAgainstAlzheimer’s President and COO, Russ Paulsen, joined Punchbowl News founder Anna Palmer for a powerful conversation on the importance of medical research funding in the fight to cure Alzheimer’s and other diseases.

Congress Increases Funding for Alzheimer’s Disease and Other Dementia Research

House and Senate Committees on appropriations released their final bipartisan FY2026 Labor–Health and Human Services–Education appropriations bill.

This November, we’re honoring Alzheimer’s Awareness Month.

Understand your brain health today — and take the first step with BrainGuide.

Join the UsAgainstAlzheimer's Membership Program

Become a Member of UsAgainstAlzheimer's today and join a movement of people who don’t just talk about the Alzheimer’s crisis, but become part of the solution.

Fifth Cohort of Brain Health Equity Nurse Fellowship

Leading the Way: Black Women Closing the Gap in Brain Health

Why Funding Alzheimer’s Research Is Urgent

Congress Increases Research Funding

Early detection can change lives.

Become a Member

VISION: UsAgainstAlzheimer's envisions a world without Alzheimer's where brainspan equals lifespan. 

MISSION: Catalyze change in the health ecosystem to improve dementia prevention, early detection, and access to treatments through advocacy, policy, convening, and high-leveraged programs, with a particular focus on health equity.   

 

Prevention

Alzheimer’s is not a normal part of aging. There are things we can all do to reduce our risk, like eating a healthy diet, exercising, and getting good sleep. People need to know what’s good for the body is good for the brain. Learn more about our prevention work and how you can take charge of your brain health.

CLICK HERE FOR MORE INFO

Early Detection & Diagnosis

Early detection and diagnosis give people a better chance of managing the disease. On top of that, current treatments are most effective with patients in the early stages of dementia.

Find out how we are raising awareness of the importance of early detection and how BrainGuide is helping people concerned about their brain health start a conversation with their doctor.

CLICK HERE FOR MORE INFO

Access to Treatments

We are working on multiple fronts to get safe and effective treatments into the hands of people who need them most. That includes working to ensure Alzheimer’s patients are treated fairly as the federal government considers drug approval and Medicare coverage for treatments.

See how else UsAgainstAlzheimer’s is fighting for access to treatments.

CLICK HERE FOR MORE INFO

 

Center for Brain Health Equity

Most Alzheimer’s patients are women, Latinos, and Black people. As a patient-centered organization, all our work is done with equity in mind, so we are addressing needs of the people who are most heavily impacted by the disease. Learn more about how UsAgainstAlzheimer’s Center for Brain Health Equity is working toward a healthcare system that works for everyone.

Recent News and Blog Posts

  • CNN Documentary Highlights Lifestyle Changes You Can Make to Combat Alzheimer’s

    Concerned about his family's history with Alzheimer's, CNN's chief medical correspondent, Dr...

    Read more
  • May 15, 2024

    FDA Decision to Fast Track Consideration of Subcutaneous Leqembi is Good News for Alzheimer’s Patients

    Washington, DC (May 14, 2024) — Eisai and Biogen, the developers of...

    Read more
  • April 16, 2024

    UsAgainstAlzheimer’s Launches 2024 Brain Health Academy

    Six new monthly sessions added to the free continuing education program for...

    Read more
  • April 16, 2024

    UsAgainstAlzheimer’s Appoints Vivian Vasallo as Vice President for Early Detection

    UsAgainstAlzheimer’s Appoints Vivian Vasallo as Vice President for Early Detection

    Read more
  • April 10, 2024

    UsAgainstAlzheimer’s Statement on Selection of Rep. Tom Cole's as Next House Appropriations Chair

    UsAgainstAlzheimer’s released the following statement in response to the appointment of U.S...

    Read more
  • March 25, 2024

    Congress Passes Bill Making Major Investments in Alzheimer’s

    Bill Increases Funding for Alzheimer’s Research and Prevention Efforts

    Read more

Reports

  • Resources
    report

    2024 Annual Report

  • Resources
    2023 report

    2023 Annual Report

  • Resources

    2022 Annual Report